Profile
| Metric | Value |
|---|---|
| Full Name | Align Technology, Inc. |
| Ticker | NASDAQ: ALGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | aligntech.com |
| Employees | 20,945 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $171.49 | |
| Price, 1D Change | +0.01% | |
| Market Cap | $12B | |
| - | ||
| PE Ratio | 33.23 | |
| Beta | 1.25 | |
| Revenue | $4B | |
| Revenue, 1Y Change | +3.54% | |
| EPS | $5.62 | |
| EPS, 1Y Change | -3.33% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.62 | |
| EPS Estimate | $10.19 | |
| EPS Est. Change | +81.40% | |
| Revenue | $4.00B | |
| Revenue Estimate | $4.03B | |
| Revenue Est. Change | +0.77% | |
| Current Price | $171.49 | |
| Price Target | - | $180.00 |
| Price Tgt. Change | - | +4.96% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.34 | $5.81 | -30.31% | |
| $9.33 | $5.62 | -39.78% | |
| $10.19 | N/A | +81.40% | |
| $11.00 | N/A | +95.69% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.84B | $3.86B | +0.71% | |
| $4.00B | $4.00B | -0.07% | |
| $4.03B | N/A | +0.77% | |
| $4.18B | N/A | +4.63% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -21.66% | |
| Price, 3Y | -28.47% | |
| Market Cap, 1Y | -23.89% | |
| Market Cap, 3Y | -33.58% | |
| Revenue, 1Y | +3.54% | |
| Revenue, 3Y | +1.17% | |
| EPS, 1Y | -3.33% | |
| EPS, 3Y | -42.02% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $171.49 | |
| SMA 200 | $159.20 | |
| SMA 200 vs Price | -7.17% | |
| SMA 50 | $154.03 | |
| SMA 50 vs Price | -10.18% | |
| Beta | 1.25 | |
| ATR | $4.24 | |
| 14-Day RSI | 67.93 | |
| 10-Day Volatility | 29.07% | |
| 1-Year Volatility | 52.62% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.00B | |
| EPS | $5.62 | |
| Gross Profit | $2.82B | |
| Gross Margin | 70.55% | |
| Operating Profit | $671.76M | |
| Operating Margin | 16.80% | |
| Net Income | $421.36M | |
| Net Margin | 10.54% | |
| EBITDA | $816.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.03 | |
| Current Ratio | 1.22 | |
| Quick Ratio | 1.10 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 4.77 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 33.23 | |
| PS Ratio | 3.09 | |
| PB Ratio | 3.11 | |
| EV/EBITDA | 14.19 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $3.85B | |
| Cash & Equivalents | $1.04B | |
| Total Assets | $6.21B | |
| Current Assets | $2.49B | |
| Total Liabilities | $2.36B | |
| Current Liabilities | $2.04B | |
| Total Debt | $119.28M | |
| Short Term Debt | $31.06M | |
| Accounts Payable | $108.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.58B | |
| Operating Expenses | $2.15B | |
| Cost Of Goods Sold | $1.18B | |
| SG&A | $0.00 | |
| D&A | $145.03M | |
| Interest Expense | $0.00 | |
| Income Tax | $187.60M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $738.23M | |
| CFI | -$254.91M | |
| CFF | -$355.72M | |
| Capex | $115.58M | |
| Free Cash Flow | $622.65M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| Wells Fargo | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Evercore ISI Group | → | |
| Morgan Stanley | → | |
| UBS | → | |
| Mizuho | → | |
| Jefferies | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with ALGN
FAQ
What is the ticker symbol for Align Technology, Inc.?
The ticker symbol for Align Technology, Inc. is NASDAQ:ALGN
Does Align Technology, Inc. pay dividends?
No, Align Technology, Inc. does not pay dividends
What sector is Align Technology, Inc. in?
Align Technology, Inc. is in the Healthcare sector
What industry is Align Technology, Inc. in?
Align Technology, Inc. is in the Medical Instruments & Supplies industry
What country is Align Technology, Inc. based in?
Align Technology, Inc. is headquartered in United States
When did Align Technology, Inc. go public?
Align Technology, Inc. initial public offering (IPO) was on January 30, 2001
Is Align Technology, Inc. in the S&P 500?
Yes, Align Technology, Inc. is included in the S&P 500 index
Is Align Technology, Inc. in the NASDAQ 100?
No, Align Technology, Inc. is not included in the NASDAQ 100 index
Is Align Technology, Inc. in the Dow Jones?
No, Align Technology, Inc. is not included in the Dow Jones index
When was Align Technology, Inc. last earnings report?
Align Technology, Inc.'s most recent earnings report was on October 29, 2025
When does Align Technology, Inc. report earnings?
The next expected earnings date for Align Technology, Inc. is February 4, 2026
Data Sources & References
- ALGN Official Website www.aligntech.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1097149/000109714925000075/0001097149-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1097149/000109714925000012/0001097149-25-000012-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ALGN Profile on Yahoo Finance finance.yahoo.com/quote/ALGN
- ALGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algn